GO:0004435 phosphatidylinositol-4,5-bisphosphate phospholipase C activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004435 describes the enzymatic activity that hydrolyzes phosphatidylinositol-4,5-bisphosphate (PIP2) into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG), two universal second messengers.
• This activity is executed by phospholipase C (PLC) enzymes, which are recruited to membranes and activated by G-protein-coupled receptors and receptor tyrosine kinases.
• PIP2 availability and PLC activity are tightly coupled to phosphatidylinositol transfer proteins (PITPs) that replenish PIP2 at the plasma membrane.
• Dysregulated PLC signaling contributes to cancer, neurodegeneration, and immune disorders, making this activity a therapeutic target.
• CRISPR knockout, point-mutation, and knock-in models enable precise dissection of PLC isoform-specific functions in cells and organisms.
• Studying GO:0004435 requires combining lipid biochemistry, live-cell imaging, and genetic perturbation to link enzyme activity to downstream calcium and PKC signaling.
Description
Phosphatidylinositol-4,5-bisphosphate phospholipase C activity (GO:0004435) is a molecular function that catalyzes the hydrolysis of phosphatidylinositol-4,5-bisphosphate (PIP2) to generate inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). This reaction is a central node in signal transduction, converting a membrane lipid into two second messengers that control calcium release and protein kinase C activation. Researchers study this activity to understand how cells translate extracellular signals into diverse physiological responses, including secretion, contraction, proliferation, and migration. The reaction is not spontaneous; it requires phospholipase C (PLC) enzymes, which are regulated by heterotrimeric G proteins, receptor tyrosine kinases, and calcium. Because PIP2 is also a substrate for other enzymes and a regulator of ion channels and cytoskeletal proteins, its hydrolysis by PLC must be spatially and temporally controlled. This article integrates the QuickGO definition with verified literature to provide a research-grade overview of GO:0004435, its gene families, disease relevance, and experimental strategies for functional studies.
phosphatidylinositol-4,5-bisphosphate phospholipase C activity At A Glance
| GO ID | GO:0004435 |
|---|---|
| GO term | phosphatidylinositol-4,5-bisphosphate phospholipase C activity |
| Ontology | molecular_function |
| Synonym | PI-PLC activity; phosphoinositide phospholipase C activity; phosphoinositidase C activity; 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase activity |
| Major function | Hydrolysis of PIP2 to IP3 and DAG, generating second messengers for calcium signaling and PKC activation |
| Reaction | PIP2 + H2O = IP3 + DAG + H+ |
| Cofactors | Calcium is required for most PLC isoforms; some are activated by G proteins or tyrosine phosphorylation |
| Subcellular location | Plasma membrane, with substrate PIP2 enriched in the inner leaflet; also reported in nuclear and Golgi membranes |
| Regulation | Activated by G-protein-coupled receptors, receptor tyrosine kinases, and calcium; modulated by PIP2 availability and PITPs |
What Is GO:0004435?
GO:0004435 is defined as the catalysis of the reaction: a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate) + H2O = 1D-myo-inositol 1,4,5-trisphosphate + a 1,2-diacyl-sn-glycerol + H+. In simpler terms, it is the enzyme activity that cuts PIP2 into IP3 and DAG, releasing a proton. This activity is synonymous with phosphoinositide phospholipase C, PI-PLC, and phosphoinositidase C, and it is classified as a molecular function in the Gene Ontology.
Why Is phosphatidylinositol-4,5-bisphosphate phospholipase C activity Important in Cell Biology?
GO:0004435 is essential because it initiates one of the most widespread signaling cascades in eukaryotes, controlling processes as diverse as smooth muscle contraction, neuronal excitability, immune cell activation, and cell growth. The balance between PIP2 and its hydrolysis products influences membrane identity, ion channel activity, and cytoskeletal dynamics. Consequently, mutations or altered expression of PLC enzymes are linked to human diseases including cancer, neurodegeneration, and immune deficiencies.
• Generates IP3 and DAG, two second messengers that regulate intracellular calcium and protein kinase C.
• Controls smooth muscle contraction, secretion, and platelet activation through Gq-coupled receptors.
• Regulates neuronal plasticity and survival; PLCβ and PLCγ isoforms are implicated in neurodegeneration.
• Modulates immune cell signaling downstream of T-cell and B-cell receptors.
• Influences cancer cell proliferation, migration, and invasion via PLCγ and PLCε.
• PIP2 hydrolysis affects ion channels, transporters, and actin-binding proteins, linking signaling to membrane trafficking.
• Provides a biochemical readout for drug discovery targeting Gq/PLC pathways.
• Enables synthetic biology approaches to control calcium and DAG signals with light or chemical inducers.
What Happens During phosphatidylinositol-4,5-bisphosphate phospholipase C activity?
Substrate recognition and membrane recruitment
In simple terms: The enzyme must first find and bind its lipid substrate in the membrane.
Phospholipase C enzymes contain pleckstrin homology (PH) domains that bind PIP2 and phosphatidylinositol 3,4,5-trisphosphate, targeting them to the plasma membrane. In resting cells, PIP2 is concentrated in the inner leaflet, and PLC isoforms are often cytosolic or autoinhibited until they receive activation signals. Phosphatidylinositol transfer proteins (PITPs) facilitate the transfer of phosphatidylinositol between membranes to maintain PIP2 pools at the plasma membrane, ensuring substrate availability for PLC.
Activation by upstream signals
In simple terms: Signals from outside the cell switch the enzyme on.
G-protein-coupled receptors activate PLCβ isoforms through Gαq subunits, while receptor tyrosine kinases activate PLCγ isoforms via tyrosine phosphorylation. Some PLC isoforms, such as PLCδ, are activated by calcium and may respond to changes in PIP2 levels. Additionally, phosphatidic acid can stimulate PIP2-specific PLC activity, providing a link to lipid signaling pathways. GTP-dependent hydrolysis of PIP2 by soluble PLC from human epidermis has been demonstrated, indicating that GTP-binding proteins regulate this activity in some tissues.
Catalytic hydrolysis of PIP2
In simple terms: The enzyme cuts PIP2 into two messenger molecules.
The catalytic domain of PLC hydrolyzes the phosphodiester bond of PIP2, yielding IP3 and DAG. This reaction requires calcium for most isoforms, which coordinates the phosphate groups and stabilizes the transition state. The products have distinct fates: IP3 is soluble and diffuses to the endoplasmic reticulum to trigger calcium release, while DAG remains in the membrane and activates protein kinase C. The reaction also releases a proton, contributing to local pH changes.
Termination and resynthesis of PIP2
In simple terms: The signal is turned off and the substrate is regenerated.
IP3 is dephosphorylated by inositol polyphosphate 5-phosphatases and other enzymes, while DAG is either phosphorylated to phosphatidic acid or used for protein kinase C activation. PIP2 is resynthesized from phosphatidylinositol by PI4 kinases and PIP5 kinases, a process that requires PITPs to replenish the substrate pool. Synaptojanin, a polyphosphoinositide phosphatase, can inhibit phospholipase D by hydrolyzing PIP2, illustrating crosstalk between lipid signaling enzymes.
Cellular consequences of PLC activity
In simple terms: The products change cell behavior.
IP3-mediated calcium release regulates contraction, secretion, gene expression, and cell death. DAG activates protein kinase C isoforms, which phosphorylate targets involved in proliferation, differentiation, and migration. PLCδ1 affects integrin-mediated cell adhesion and migration by altering available PIP2 levels, demonstrating that PLC activity can remodel the plasma membrane landscape. In liver, 4-hydroxylalkenals modulate hepatic PIP2-PLC, suggesting that oxidative stress can influence this activity.
Key Genes Involved in GO:0004435 phosphatidylinositol-4,5-bisphosphate phospholipase C activity
The following genes encode proteins that either execute or directly regulate phosphatidylinositol-4,5-bisphosphate phospholipase C activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PLCB1 | Gq-coupled PLCβ isoform; hydrolyzes PIP2 in neurons and other tissues | Implicated in epilepsy and neuronal signaling; knockout models show altered behavior |
| PLCB2 | PLCβ isoform enriched in hematopoietic cells | Regulates immune cell activation and chemotaxis |
| PLCB3 | PLCβ isoform activated by Gαq | Studied in smooth muscle contraction and platelet function |
| PLCB4 | PLCβ isoform in brain and retina | Linked to synaptic transmission and sensory signaling |
| PLCG1 | Tyrosine kinase-activated PLCγ; hydrolyzes PIP2 downstream of growth factor receptors | Oncogenic role in cancer; target for inhibitor development |
| PLCG2 | PLCγ isoform in immune cells | Mutations cause immune dysregulation; knockout models available |
| PLCD1 | Calcium-activated PLCδ isoform | Regulates cell adhesion and migration via PIP2 availability |
| PLCD3 | PLCδ isoform in various tissues | Studied in epidermal differentiation and calcium signaling |
| PLCE1 | PLCε isoform activated by Ras and G proteins | Implicated in cancer and kidney disease |
| PLCH1 | PLCη isoform in brain | Potential role in neuronal development |
| PLCH2 | PLCη isoform | Less characterized; may modulate synaptic function |
| PLCL1 | PLC-like protein lacking catalytic activity | May act as a scaffold or regulator |
| PLCL2 | PLC-like protein | Studied in immune signaling |
| PITPNA | Phosphatidylinositol transfer protein alpha | Maintains PIP2 pools for PLC; knockout affects signaling |
| PITPNB | Phosphatidylinositol transfer protein beta | Bridges ER and plasma membrane for PIP2 resynthesis |
| SYNJ1 | Synaptojanin 1; polyphosphoinositide phosphatase | Hydrolyzes PIP2 and inhibits phospholipase D; linked to Parkinsonism |
| GNAQ | Gαq subunit that activates PLCβ | Mutations in uveal melanoma drive constitutive PLC activity |
| GNA11 | Gα11 subunit activating PLCβ | Mutations in uveal melanoma and other cancers |
How Is phosphatidylinositol-4,5-bisphosphate phospholipase C activity Regulated?
Phosphatidylinositol-4,5-bisphosphate phospholipase C activity is regulated at multiple levels. Upstream, G-protein-coupled receptors and receptor tyrosine kinases activate specific PLC isoforms through Gαq or phosphorylation. Calcium directly activates PLCδ isoforms and modulates others, creating feedback loops. Substrate availability is controlled by PITPs and lipid kinases that replenish PIP2. Phosphatidic acid can stimulate PLC activity, linking phospholipase D and PLC pathways. GTP-binding proteins regulate soluble PLC in some tissues. Finally, phosphatases such as synaptojanin hydrolyze PIP2, thereby limiting substrate and modulating PLC output.
phosphatidylinositol-4,5-bisphosphate phospholipase C activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PLCG1 | Cancer (breast, prostate); cell proliferation and migration | Knockout and point-mutation cell lines; xenograft models |
| GNAQ | Uveal melanoma; constitutive PLCβ activation | Knock-in of mutant GNAQ in melanocytes; organoid models |
| PLCG2 | Immune dysregulation; autoimmunity | Knockout mice and human iPSC-derived immune cells |
| SYNJ1 | Parkinsonism; synaptic vesicle recycling | Knockout and knock-in neuronal cultures |
| PLCD1 | Cell adhesion and migration; potential cancer relevance | CRISPR knockout in epithelial cells; live-cell imaging |
Cancer
Dysregulated PLC signaling promotes tumor growth, survival, and metastasis. PLCγ1 is activated downstream of growth factor receptors and contributes to oncogenic signaling in breast, prostate, and other cancers. Mutations in GNAQ and GNA11, which activate PLCβ, are found in uveal melanoma and drive constitutive PIP2 hydrolysis. Targeting PLC activity or downstream effectors is an active area of drug discovery.
Neurodegeneration and neurological disorders
PLCβ1 and PLCγ1 are critical for synaptic plasticity and neuronal survival. Altered PLC activity has been observed in Alzheimer's disease and epilepsy models. Synaptojanin 1, which hydrolyzes PIP2, is linked to Parkinsonism and synaptic dysfunction. PLCδ1 affects integrin-mediated adhesion and migration, processes relevant to neuronal development.
Immune disorders
PLCG2 mutations cause immune dysregulation and autoimmunity, highlighting the importance of PIP2 hydrolysis in lymphocyte signaling. PLCβ2 and PLCβ3 regulate chemokine-induced migration of immune cells.
Metabolic and oxidative stress
In liver, 4-hydroxylalkenals, products of lipid peroxidation, modulate hepatic PIP2-PLC activity, suggesting that oxidative stress impacts this signaling axis. Phosphatidic acid stimulation of PLC links lipid metabolism to signal transduction.
From phosphatidylinositol-4,5-bisphosphate phospholipase C activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PLC isoform affect PIP2 hydrolysis and downstream calcium signals? | CRISPR knockout cell lines (e.g., PLCB1, PLCG1) |
| How do disease-associated point mutations alter PLC catalytic activity? | Point-mutation knock-in via CRISPR (e.g., PLCG2 variants) |
| Can we visualize PLC activity in live cells? | Tagged knock-in of PLC with fluorescent reporters; PIP2 biosensors |
| Does overexpression of PLC drive oncogenic transformation? | Overexpression cell models and xenografts |
| What is the role of PITPs in maintaining PIP2 pools for PLC? | Knockout of PITPNA/PITPNB; lipidomics and imaging |
| How does synaptojanin regulate PLC output? | Knockout or knockdown of SYNJ1; PIP2 measurements |
How to Study the phosphatidylinositol-4,5-bisphosphate phospholipase C activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro PLC assay | Hydrolysis of PIP2 to IP3/DAG | Enzyme kinetics and inhibitor screening |
| PIP2 biosensor imaging | Real-time PIP2 levels at membranes | Live-cell signaling dynamics |
| Calcium imaging | Intracellular calcium release | Downstream PLC activity |
| CRISPR knockout | Loss of specific PLC isoform | Functional redundancy and disease models |
| Phosphoproteomics | Tyrosine phosphorylation of PLCγ | Receptor tyrosine kinase signaling |
| Lipidomics | PIP2 and metabolite levels | Substrate availability and resynthesis |
| RNA-seq | Transcriptional changes after PLC perturbation | Pathway analysis and target discovery |
| Proximity ligation assay | Protein-protein interactions of PLC | Assembly of signaling complexes |
Lipid biochemistry and enzyme assays
In vitro PLC activity assays using radiolabeled or fluorescent PIP2 can measure hydrolysis rates and substrate specificity. These assays are useful for testing inhibitors and mutant enzymes. GTP-dependent hydrolysis can be reconstituted with purified G proteins.
Live-cell imaging of PIP2 and downstream signals
Genetically encoded PIP2 biosensors (e.g., PH domains fused to fluorescent proteins) allow real-time monitoring of PIP2 levels at the plasma membrane. Calcium indicators and PKC translocation reporters provide readouts of PLC activity.
Genetic perturbation with CRISPR
Knockout of specific PLC genes eliminates isoform-specific activity, while point mutations can dissect catalytic versus scaffolding functions. Knock-in of tagged PLC enables localization and interaction studies.
Omics and bioinformatics
RNA-seq and proteomics can reveal changes in PLC expression and signaling networks upon perturbation. Lipidomics quantifies PIP2 and its metabolites, linking enzyme activity to cellular lipid composition.
How CRISPR Can Be Used to Study GO:0004435 phosphatidylinositol-4,5-bisphosphate phospholipase C activity
Knockout
CRISPR knockout of PLC genes (e.g., PLCB1, PLCG1, PLCD1) eliminates specific PIP2 hydrolysis activity, enabling researchers to assign isoform-specific functions. Knockout cell lines are valuable for studying compensatory mechanisms and for drug target validation.
Point Mutation
Point mutations can be introduced into PLC catalytic domains or regulatory sites to dissect enzyme activation, substrate binding, and disease-associated variants. For example, mutations in PLCG2 linked to immune disorders can be modeled to test gain- or loss-of-function.
Knock-in
Knock-in of fluorescent or affinity tags into endogenous PLC loci allows visualization of protein localization and interaction without overexpression artifacts. Knock-in of disease alleles (e.g., GNAQ mutants) creates isogenic models for drug testing.
Overexpression
Overexpression of wild-type or mutant PLC isoforms can amplify signaling and reveal oncogenic potential. However, overexpression may saturate regulatory mechanisms, so results should be interpreted alongside knockout data.
How EDITGENE Supports phosphatidylinositol-4,5-bisphosphate phospholipase C activity Research
Researchers studying phosphatidylinositol-4,5-bisphosphate phospholipase C activity-related genes often need to determine whether a candidate gene is causally involved in PIP2 hydrolysis, calcium signaling, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylinositol-4,5-bisphosphate phospholipase C activity research.
Frequently Asked Questions About phosphatidylinositol-4,5-bisphosphate phospholipase C activity
What is phosphatidylinositol-4,5-bisphosphate phospholipase C activity?
It is the enzyme activity that hydrolyzes PIP2 into IP3 and DAG, two second messengers, as defined by GO:0004435.
What genes are involved in phosphatidylinositol-4,5-bisphosphate phospholipase C activity?
Genes include PLCB1, PLCB2, PLCB3, PLCB4, PLCG1, PLCG2, PLCD1, PLCD3, PLCE1, PLCH1, PLCH2, and regulators such as PITPNA and SYNJ1.
What is the GO ID for phosphatidylinositol-4,5-bisphosphate phospholipase C activity?
The GO ID is GO:0004435.
How is phosphatidylinositol-4,5-bisphosphate phospholipase C activity regulated?
It is regulated by G-protein-coupled receptors, receptor tyrosine kinases, calcium, phosphatidic acid, and PIP2 availability maintained by PITPs.
What diseases are associated with phosphatidylinositol-4,5-bisphosphate phospholipase C activity?
Dysregulation is linked to cancer, neurodegeneration, immune disorders, and oxidative stress-related conditions.
What are the products of phosphatidylinositol-4,5-bisphosphate phospholipase C activity?
The products are inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG), plus a proton.
Which phospholipase C isoforms are activated by G proteins?
PLCβ isoforms (PLCB1-4) are activated by Gαq subunits, while PLCγ isoforms are activated by tyrosine kinases.
How can I study phosphatidylinositol-4,5-bisphosphate phospholipase C activity in the lab?
Common methods include in vitro enzyme assays, PIP2 biosensor imaging, calcium imaging, and CRISPR knockout of specific PLC genes.
What is the role of PIP2 in cells?
PIP2 is a membrane lipid that serves as a substrate for PLC and also regulates ion channels, transporters, and cytoskeletal proteins.
Can CRISPR be used to model diseases related to phosphatidylinositol-4,5-bisphosphate phospholipase C activity?
Yes, CRISPR knockout, point mutation, and knock-in models can replicate disease-associated variants in PLC genes and regulators.
Conclusion
GO:0004435, phosphatidylinositol-4,5-bisphosphate phospholipase C activity, is a cornerstone of cellular signal transduction, converting PIP2 into the second messengers IP3 and DAG. Its regulation by G proteins, tyrosine kinases, calcium, and lipid transfer proteins ensures precise control of diverse physiological processes. Dysregulation of this activity contributes to cancer, neurodegeneration, and immune disorders, making it a compelling target for basic and translational research. Advances in CRISPR-based models and live-cell imaging continue to illuminate isoform-specific functions and therapeutic opportunities.
References
- 1. Cockcroft S et al.. 2016. Topological organisation of the phosphatidylinositol 4,5-bisphosphate-phospholipase C resynthesis cycle: PITPs bridge the ER-PM gap.. Biochem J 473(23):4289-4310 PMID: 27888240
- 2. Katan M et al.. 2020. Phosphatidylinositol(4,5)bisphosphate: diverse functions at the plasma membrane.. Essays Biochem 64(3):513-531 PMID: 32844214
- 3. Kadamur G et al.. 2013. Mammalian phospholipase C.. Annu Rev Physiol 75:127-54 PMID: 23140367
- 4. Jackowski S et al.. 1989. Stimulation of phosphatidylinositol 4,5-bisphosphate phospholipase C activity by phosphatidic acid.. Arch Biochem Biophys 268(2):516-24 PMID: 2536532
- 5. Yoneda A et al.. 2026. Phospholipase C δ1 affects integrin-mediated cell adhesion and migration by altering available phosphatidylinositol 4,5-bisphosphate levels.. Exp Cell Res 455(1):114857 PMID: 41391593
- 6. Fisher GJ et al.. 1989. GTP-dependent hydrolysis of phosphatidylinositol-4,5-bisphosphate by soluble phospholipase C from adult human epidermis.. J Invest Dermatol 92(6):831-6 PMID: 2542416
- 7. Chung JK et al.. 1997. Synaptojanin inhibition of phospholipase D activity by hydrolysis of phosphatidylinositol 4,5-bisphosphate.. J Biol Chem 272(25):15980-5 PMID: 9188500
- 8. Rossi MA et al.. 1990. Effect of 4-hydroxylalkenals on hepatic phosphatidylinositol-4,5-bisphosphate-phospholipase C.. Biochem Pharmacol 39(11):1715-9 PMID: 2160819
